Maximum Dose of Propranolol (Inderal) for Tachycardia
For acute intravenous treatment of supraventricular tachycardia, the maximum dose of propranolol is 3 mg total (given as 1 mg IV over 1 minute, repeated at 2-minute intervals up to 3 doses). 1
Intravenous Dosing for Acute Tachycardia
The 2015 ACC/AHA/HRS guideline provides clear dosing parameters for IV propranolol in acute SVT management 1:
- Initial dose: 1 mg IV administered over 1 minute
- Repeat dosing: Can repeat 1 mg IV at 2-minute intervals
- Maximum total: Up to 3 doses (3 mg total)
Key Precautions
Contraindications and cautions include 1:
- AV block greater than first degree or SA node dysfunction (without pacemaker)
- Decompensated systolic heart failure
- Hypotension or cardiogenic shock
- Reactive airway disease
- Concurrent use with other SA/AV nodal-blocking drugs
Adverse Effects to Monitor
Watch for hypotension, worsening heart failure, bronchospasm, and bradycardia during IV administration 1.
Oral Dosing Considerations
While the FDA label does not specifically address maximum dosing for tachycardia treatment, it provides context for other indications 2:
- Hypertension: Maximum documented dose is 640 mg daily
- Angina: Safety beyond 320 mg daily has not been established
- General guidance: The sustained-release formulation (Inderal LA) is not a simple mg-for-mg substitute for immediate-release propranolol
Clinical Context from Research
For postural tachycardia syndrome (POTS), lower doses are paradoxically more effective. Research demonstrates that 20 mg oral propranolol improved symptoms better than 80 mg, despite the higher dose producing greater heart rate reduction 3. This "less is more" phenomenon suggests that excessive beta-blockade may worsen symptoms even while controlling heart rate.
Studies in normal subjects show that approximately 160 mg daily propranolol achieves near-maximal cardiac beta-blockade 4, and plasma levels above 20 ng/mL induce significant beta blockade 5.
Clinical Algorithm
For acute tachycardia requiring IV treatment:
- Give 1 mg IV over 1 minute
- Assess response after 2 minutes
- If inadequate, repeat 1 mg IV (maximum 3 total doses)
- Monitor continuously for hypotension and bradycardia
For chronic oral management of tachycardia:
- Start low (20-40 mg daily for conditions like POTS)
- Titrate based on symptom response, not just heart rate control
- Recognize that doses above 160-240 mg daily rarely provide additional benefit for rate control and may worsen tolerability
- Consider that the therapeutic window is narrower than you might expect
Critical Pitfall
Do not assume higher doses are better for tachycardia control. The evidence shows that excessive beta-blockade can paradoxically worsen symptoms despite achieving greater heart rate reduction 3. This is particularly important in functional tachycardias like POTS where autonomic balance matters more than absolute heart rate numbers.